Coronary atherosclerotic heart disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Aged 35 to 85 years; (2) Patients with coronary heart disease (we should have the diagnostic basis of coronary heart disease: for example, at least one coronary artery stenosis (> 50%) confirmed by coronary angiography, or confirmed by coronary CTA, or old history of myocardial infarction, or pathological Q wave of ECG, or supported by electrocardiogram stress test and radionuclide examination); (3)Patients with stable coronary heart disease((Occult Coronary Heart Disease, Stable Angina Pectoris or Acute Coronary Syndrome over a Month) (4) Sign the informed consent and volunteer to participate in the research.
Exclusion criteria
Exclusion criteria: (1) Patients with infection, fever, trauma, burns, surgical history or active tuberculosis or rheumatic immune disease in the past week; (2) Patients with acute exacerbation of chronic obstructive pulmonary disease or pulmonary heart disease or respiratory failure; (3) Patients with acute and subacute cerebrovascular diseases; (4) Severe primary diseases such as hematopoietic system or malignant tumors; (5) Organ transplantation patients; (6) Severe mental disorders (sensory disorders, thinking disorders); (7) Those with difficulty in language expression or poor comprehension; (8) Pregnant women and lactating women; (9) Researchers believe that there are other situations that are not suitable for this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Four Diagnostic Information on syndrome of intermingled phlegm and blood stasis in patients with coronary atherosclerotic heart disease;Expert Syndrome Differentiation Information; | — |
Secondary
| Measure | Time frame |
|---|---|
| Basic information of patients;Disease-related information;Medication situation; | — |
Countries
China
Contacts
Institute of Basic Theory of Chinese Medicine, China Academy of Chinese Medicine Science